Select language:  
1800 620 420
Close menu

Survivor Eleanor proving a gift in Will is ageless

Before undergoing her life-saving transplant at just 23-years-old, Eleanor made a lasting commitment to the blood cancer community through her gift in Will.

  • Our supporters
Read more
Eleanor Colla with the Thai medical team who cared for her

Thank you for keeping Jamie safe

Thanks to donors, Jamie's family has had a safe place to call home during blood cancer treatment.

  • Our supporters
Read more
Smiling young child pushes a teddy bear in a toy truck

Helping people with blood cancer during COVID-19

Supporter generosity has supported a huge COVID-19 outreach program.

Read more
Leukaemia Foundation staff member Lara takes a video call with a patient

Light the Night … at Home – Record numbers sign up early for reimagined event as COVID-19 forces transformation

  • Media releases
Read more
Light the Night 2020

Q&A: Dr Peter Diamond – our head of research

Head of the Leukaemia Foundation’s National Research Program, Dr Peter Diamond discusses his role, priorities for the program, and exciting breakthroughs coming up in blood cancer research. 

  • Research
Read more
Dr Peter Diamond

Blood Cancer Taskforce develops national plan

The Blood Cancer Taskforce has brought the Australian blood cancer community together to develop the first National Strategic Action Plan for Blood Cancer.  

  • Acute myeloid leukaemia
  • Advocacy and policy
  • Chronic myeloid leukaemia
Read more
Australia icon

New Leukaemia Foundation Website Launches today

  • Media releases
Read more
Illustration of person looking at the Leukaemia Foundation website

Searching for “more effective and gentler” therapies for AML

The Professor of Harvard University’s Department of Stem Cell and Regenerative Biology spoke with us about why he chose this line of work, and his research objectives.

  • Acute myeloid leukaemia
  • Research
Read more
David-Scadden-therapies-for-AML

Expert interview series: Dr David Yeung discusses CML

The researcher and haematologist takes us on a deep dive into chronic myeloid leukaemia.

  • Chronic myeloid leukaemia
  • Interviews with experts
  • Research
Read more
David Yeung

 Adding the microenvironment to the AML therapy mix improves efficacy   

Associate Professor Ingrid Wrinkler's findings have "opened up a whole new field".

  • Acute myeloid leukaemia
  • Research
Read more
Ingrid Winker and Valerie Barbier